SLCO1B3 and cervical squamous intraepithelial neoplasia: The genetic variants that have been identified to date for CIA and CIN as an adverse drug reaction (i.e., variants in HLA-DQB1, HLA-B, and SLCO1B3/SLCO1B7) do not fulfill the criteria for a predictive genetic test [79].